Keywords: Lung, COVID-19Gas exchange hyperpolarized 129Xe MRI (Xe-MRI) is increasingly being considered as an outcome measure in multi-site clinical trials, but there is limited evidence of between-site comparability. In this study, we analyzed 121 gas exchange Xe-MRI images in healthy and post-acute COVID-19 participants independently acquired at three sites. In healthy volunteers, quantitative Xe-MRI measures are indistinguishable across sites. In post-acute COVID-19, cross-site differences in Xe-MRI measures are evident but appear to be driven by differences in patient population. Moreover, Xe-MRI measures across sites correlate strongly with pulmonary function testing. These results support the feasibility of multi-site trials using gas exchange Xe-MRI.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords